Anti-TYR monoclonal antibody

Pre-made anti-TYR monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TYR/TYR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0016-Ab-1/ GM-Tg-hg-IP0016-Ab-2Anti-Human TYR monoclonal antibodyHuman
GM-Tg-rg-IP0016-Ab-1/ GM-Tg-rg-IP0016-Ab-2Anti-Rat TYR monoclonal antibodyRat
GM-Tg-mg-IP0016-Ab-1/ GM-Tg-mg-IP0016-Ab-2Anti-Mouse TYR monoclonal antibodyMouse
GM-Tg-cynog-IP0016-Ab-1/ GM-Tg-cynog-IP0016-Ab-2Anti-Cynomolgus/ Rhesus macaque TYR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0016-Ab-1/ GM-Tg-felg-IP0016-Ab-2Anti-Feline TYR monoclonal antibodyFeline
GM-Tg-cang-IP0016-Ab-1/ GM-Tg-cang-IP0016-Ab-2Anti-Canine TYR monoclonal antibodyCanine
GM-Tg-bovg-IP0016-Ab-1/ GM-Tg-bovg-IP0016-Ab-2Anti-Bovine TYR monoclonal antibodyBovine
GM-Tg-equg-IP0016-Ab-1/ GM-Tg-equg-IP0016-Ab-2Anti-Equine TYR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0016-Ab-1/ GM-Tg-hg-IP0016-Ab-2; GM-Tg-rg-IP0016-Ab-1/ GM-Tg-rg-IP0016-Ab-2;
GM-Tg-mg-IP0016-Ab-1/ GM-Tg-mg-IP0016-Ab-2; GM-Tg-cynog-IP0016-Ab-1/ GM-Tg-cynog-IP0016-Ab-2;
GM-Tg-felg-IP0016-Ab-1/ GM-Tg-felg-IP0016-Ab-2; GM-Tg-cang-IP0016-Ab-1/ GM-Tg-cang-IP0016-Ab-2;
GM-Tg-bovg-IP0016-Ab-1/ GM-Tg-bovg-IP0016-Ab-2; GM-Tg-equg-IP0016-Ab-1/ GM-Tg-equg-IP0016-Ab-2
Products NameAnti-TYR monoclonal antibody
Formatmab
Target NameTYR
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TYR monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0016-Ag-1Recombinant multi-species TYRO/ TYR/ ATN protein
    ORF Viral VectorvGMAP000437Human TYR Adenovirus particle
    ORF Viral VectorpGMAP000129Human TYR Adenovirus plasmid
    ORF Viral VectorpGMAP000437Human TYR Adenovirus plasmid
    ORF Viral VectorvGMAP000129Human TYR Adenovirus particle


    Target information

    Target IDGM-IP0016
    Target NameTYR
    Gene ID7299,22173,308800,705792,403405,751100,280951,100060227
    Gene Symbol and Synonymsalbino,ATN,c,CMM8,OCA1,OCA1A,OCAIA,SHEP3,skc35,TYR
    Uniprot AccessionP14679,P54834,P55033,Q8MIU0
    Uniprot Entry NameTYRO_HUMAN,TYRO_FELCA,TYRO_CANLF,TYRO_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseN/A
    Gene EnsemblENSG00000077498
    Target ClassificationCheckpoint-Immuno Oncology

    The target: TYR, gene name: TYR, also named as ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3. The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.